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Abstract
Background: Methicillin resistant Staphylococcus hominis (MRSHo) are important human pathogens in immunocompro-
mised patients. However, little is known regarding its population structure and staphylococcal chromosomal cassette mec
(SCCmec) content.
Methodology/Principal Findings: To assess the population structure and the SCCmec content of S. hominis, 34 MRSHo and
11 methicillin-susceptible S. hominis (MSSHo) from neutropenic patients collected over a 3-year period were studied. The
genetic backgrounds of S. hominis isolates were analyzed by pulsed-field gel electrophoresis (PFGE) and SCCmec types were
determined by PCR. Cassette chromosome recombinases (ccr) were characterized by PCR and ccrB sequencing. The 34 S.
hominis isolates were classified into as many as 28 types and 32 subtypes (SID=99.82%); clonal dissemination was
occasionally observed. The main SCCmec structures identified were SCCmec type VI (4B) (20%), SCCmec VIII (4A) (15%), and a
new SCCmec composed of mec complex A in association with ccrAB1 (38%); 27% of the isolates harbored non-typeable
SCCmec. Overall, a high prevalence of mec complex A (73.5%), ccrAB1 (50%) and ccrAB4 (44%) were found. Importantly,
ccrB1 and ccrB4 from both MRSHo and MSSHo showed a high nucleotide sequence homology with those found in S. aureus
SCCmec I, VI and VIII respectively (.95%).
Conclusions/Significance: The S. hominis population showed a limited clonality and a low genetic diversity in the allotypes
of ccr and classes of mec complex. Moreover, our data suggest that S. hominis might have been a privileged source of mec
complex A, ccrB1 and ccrB4, for the assembly of primordial SCCmec types.
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Introduction
Coagulase-negative staphylococci (CoNS) are the most fre-
quently isolated bacteria from blood cultures of febrile neutropenic
patients mostly in association with the use of intravenous catheters
and are a predominant cause of nosocomial infections [1].
Methicillin-resistant S. epidermidis (MRSE), S. haemolyticus
(MRSHae) and S. hominis (MRSHo) are all capable of causing
infections and usually are more likely to be multiple resistant to
antimicrobial agents than other CoNS. Among staphylococci,
MRSHo is of increasing concern and today represents the third
most common organism among clinical isolates of MRCoNS
[2,3,4]. In spite of its clinical significance very little information on
the epidemiology of MRCoNS has been published. In particular
no information is available regarding S. hominis population
structure, genetic diversity and capacity of dissemination. The
whole genome sequencing of S. hominis was recently completed and
was determined for two strains: S. hominis strain SK119 and S.
hominis subsp. hominis C80 (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=genomeprj&term=38759). Analysis of the nucleotide
sequences available showed that both strains lack the determinant
of methicillin resistance (mecA), but are multidrug resistant and
exhibit resistance to several metal ions. Moreover, they contain a
high number of transposases.
Methicillin resistance conferred by the presence of the mecA
gene, encodes for an extra penicillin binding protein (PBP2A) with
low affinity for all ß-lactams [5]. The mecA gene is found inside a
mobile genetic element designated staphylococcal cassette chro-
mosome mec (SCCmec) [6], composed of two essential elements; the
mec complex that contains mecA and intact or truncated forms its
regulators (mecI and mecR1) and the ccr complex composed of
cassette chromosome recombinases (ccr) that are involved in the
integration and excision of the cassette [7]. Up until now, ten
major types of SCCmec (type I to X) have been reported in S.
aureus, that result from specific associations between a particular ccr
gene allotype and class of mec complex (A–D) [8,9]. Several SCC-
like elements that do not carry mecA but contain other
characteristic genes (e.g., capsule gene cluster, fusidic acid
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21940resistance, or the mercury resistance operon) [8, 10, 11 12] have
also been described [13,14,15].
Although the majority of the work on the characterization of
SCCmec has been carried out in MRSA, this element has been
described as well in other CoNS namely in S. epidermidis, S. hominis,
S. capitis, S. sciuri, S. warneri and S. saprophyticus [4].
Several recent reports suggest that in CoNS, SCCmec structures
are highly diverse. In a large study of S. epidermidis it was observed
that SCCmec IV and III were the most common, however, as
much as 12% of isolates carried either new or non-typeable
SCCmec types [16]. Data on SCCmec carried by S. hominis is scarce.
In the few isolates characterized so far, SCCmec types Ib, III and
new SCCmec types (1A, 1+4A, 5B) have been reported
[7,17,18,19] as well as non-typeable SCCmec structures [17,4].
Besides carrying SCCmec and SCC-like cassettes, CoNS were
suggested to be active players in the assembly of these mobile
genetic elements. Previous studies have shown that a mecA
homologue, ubiquitous in Staphylococcus sciuri, may have been the
evolutionary precursor of mecA - the structural gene encoding
PBP2a [20] and that the ccr and mec complexes from an unknown
source were probably brought together in other CoNS [21], before
the cassette was transferred into S. aureus [22]. Also, the recent
finding of a 99% of nucleotide sequence homology between the
SCCmec IV from S. epidermidis and S. aureus showed that SCCmec IV
in S. aureus was probably originated in S. epidermidis [23]. Similarly,
the discovery of regions of high homology between a SCC non-mec
containing ccrAB1 from S. hominis and SCCmec type I from S. aureus,
lead to the suggestion that this SCC non-mec from S. hominis could
have been the primordial form of SCCmec I [12]. Still several links
are missing in the evolutionary history of SCCmec and the
contribution of each CoNS species to SCCmec evolution is not
known.
In this study, we provide what we believe are the first insights
into the molecular epidemiology of S. hominis through the
description of the diversity of clonal types in MRSHo and
MSSHo and SCC elements in isolates from neutropenic patients
collected at the bone marrow transplant centre of Tunisia. We also
provide a detailed analysis on the most likely contribution of S.
hominis to SCCmec evolution.
Materials and Methods
Ethics Statement
This study was performed with approval from the Local
Medical Ethical Committee of Charles Nicolle Hospital, Tunis,
Tunisia. Since the strains were de-identified and analyzed
anonymously and the strains, not a human, were studied, this is
exempt from human research committee approval according to
the regulations of the Local Medical Ethical Committee of Charles
Nicolle Hospital, Tunis, Tunisia and informed consent is not
required according to the Ethical Committee.
Bacterial isolates
A total of 34 nosocomial MRSHo isolates consecutively sampled
between 2002 and 2004 from neutropenic patients hospitalized at
the bone marrow transplant centre of Tunisia, and recovered from
blood cultures (29.4%), intravenous catheters (29.4%) and other
specimens (41.2%), were analyzed. Isolates were hospital-acquired
(specimens collected from patients hospitalized in the graft or
hematological units (20), more than 48 h after admission, or from
patients that had a history of hospitalization within 6 months prior
the isolation date). The study included only one clinical isolate per
patient. A group of 11 MSSHo collected over the same time
period was included for molecular characterization of ccr genes.
Control isolates
S. aureus ATCC25923 [24] and S. epidermidis RP62A [25] were
included for quality control of antimicrobial susceptibility patterns.
The type strain of S. hominis ATCC27844
T was used as reference
for ITS-PCR identification. S. aureus NCTC10442, N315, 85/
2082, JCSC4744, WIS and HDE288 [6,26–29] were included as
controls for SCCmec type I, II, III, IV, V and VI, respectively. S.
aureus strain COL [30] was used as a source for the mecA probe and
as positive control for ccrAB1 in hybridization assays; S. aureus WIS
[29] was additionally used as a source for the ccrC probe; S.
epidermidis RP62A was used as an internal control of PFGE and as
a source of ccrAB2 probe; S. aureus 85/2082 was used as a positive
control for ccrAB3 and ccrC in hybridization assays; S. epidermidis
ATCC12228 [31] was used as positive control for ccrAB2 and
ccrAB4; and HDE288 [6] was used as a source of ccrAB4 probe.
Species identification
All isolates were tested by conventional identification pheno-
typic methods: mannitol fermentation, Gram staining, catalase,
coagulase tests (BBL Coagulase Plasma Rabbit test, Becton
Dickinson Microbiology systems, Cockeysville, USA) and DNAase
activity. Isolates were characterized at the species level by API ID
32 STAPH system (BioMe ´rieux, Marcy l9Etoile, France) according
to manufacturer’s instructions. Species identification was con-
firmed by ITS-PCR, as described [32].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using the disk
diffusion method on Muller-Hinton agar (Difco, Detroit, USA)
according to the recommendation of the French Society of
Microbiology «Comite ´d el 9Antibiogramme de la Socie ´te ´F r a n c ¸aise
de Microbiologie» (CA-SFM) (http://www.sfm.asso.fr). Antimicrobial
agents tested included penicillin G (6 mg, 10UI), oxacillin (5 mg),
cefoxitin (30 mg), cotrimoxazole (1,25/23,75 mg), streptomycin (10UI),
amoxicillin (25 mg), amoxicillin-clavulanic-acid (20/10 mg), gentami-
cin (15 mg), kanamycin (30 mg), tobramycin (10 mg), erythromycin
(15UI), pristinamycin (15 mg), lincomycin (15 mg), tetracycline (30 mg),
chloramphenicol (30 mg), rifampicin (30 mg), ofloxacin (5 mg), cipro-
floxacin (5 mg), vancomycin (30 mg), teicoplanin (30 mg), fosfomycin
(50 mg), and fusidic acid (10 mg) (Sanofi Diagnostics Pasteur).
Methicillin resistance was confirmed by oxacillin (5 mg) and
cefoxitin (30 mg) disc diffusion tests after 24 h incubation at 37uC.
The minimum inhibitory concentration (MIC) for oxacillin was
determined by E-test (AB-biodisk, Dalvogen, Sweden) on Muller-
Hinton agar (Difco, Detroit, USA) and interpreted as recom-
mended by CA-SFM (http://www.sfm.asso.fr). Multiresistance
was defined as resistance to three or more antimicrobial classes.
DNA preparation
DNA for PFGE was prepared as described [33,34]. Genomic DNA
for PCR was extracted as described before [32]. DNA probes for mecA,
ccrAB1, ccrAB2, ccrAB4 and ccrC were prepared using previously
described primers [35,36] followed by purification by the Wizard
PCR preps DNA Purification System (Promega, Madison, WI).
Detection of the mecA gene
The presence of mecA was determined by amplification by PCR
[36] and confirmed for all isolates by hybridizing the XhoI (or
ClaI) restriction band patterns with a DNA probe for mecA.
PFGE typing
PFGE was performed as described [33,37] with the following
modifications. XhoI (20 units/disk) was chosen as the restriction
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block1- pulse times 2 to 20 s, running time 11 h and block2- pulse
times 2 to 7 s, running time 15 h; voltage 6V; angle 120u [38].
Low Range Lambda ladder DNA (New England BioLabs,
Beverly, USA) was used as molecular weight PFGE marker. S.
epidermidis RP62A was used to access inter-gel reproducibility.
XhoI PFGE restriction band patterns were analyzed by visual
inspection by counting the number of band differences; and
automatically using BioNumerics Software (version 4. 5) from
Applied Maths (Sint-Martens-Latem, Belgium). Clusters (PFGE
types) were defined using the Dice similarity coefficient and the
unweighted pair group method with arithmetic means (UPGMA),
with 1% of tolerance and 0.8% optimization, using a cutoff
similarity value of 90%. PFGE types were identified by letters; and
subtypes were identified by letters followed by a numeric subscript.
Southern blotting and DNA hybridization
XhoI DNA fragments in PFGE gels, were transferred by
vacuum blotting as previously described [39] and hybridized with
a DNA probe for mecA using ECL direct Prime Labeling and
detection systems (Amersham Biosciences, Buckinghamshire,
United Kingdom), according to manufacturer’s instructions.
Analysis of SCCmec structure
The structures of ccr and mec complex were determined by
conventional PCR reactions as described by Okuma et al. [35].
The ccrAB4 was detected by PCR amplification using the primers
described by Oliveira et al. [40]. The mec complex C1 was
amplified by PCR using the primers defined by Katayama et al.
[41]. As a first approach, SCCmec types in S. hominis were defined
by the combination of the type of ccr complex and the class of mec
complex [29,35] using the guidelines proposed for S. aureus by the
International Working Group on the Classification of Staphylo-
coccal Cassette Chromosome Elements (IWG-SCC) [8]. SCCmec
was considered as non-typeable when ccr, the mec complex or both
were non-typeable. The mec complex and ccr complex were
considered non-typeable when no PCR amplification occurred for
any of the primer pairs used.
ccrB typing
The ccrB typing was performed as previously described [42].
The ccrB nucleotide sequences were compared by the construction
of an unrooted phylogenetic tree using the average distance
clustering method and the default parameters set in the ccrB typing
tool (http://www.ccrbtyping.net). The measurement of statistical
confidence of the clustering was performed by bootstrap
resampling (1,000).
Genotypic diversity
Genotypic diversity was calculated by using Simpson’s index of
diversity (SID) [43].
Results
Optimization of PFGE typing method for S. hominis
The enzyme SmaI generates a pattern of 4–5 fragments only,
using the protocol defined for S. aureus [33,37]. For this reason we
chose the enzyme XhoI and changed the running conditions. We
obtained clear, reproducible and well separated banding profiles,
containing 18–20 fragments ranging from approximately 6 to
165 Kb in size (Figure 1). The parameters that provided the best
concordance between visual and automatic clustering classifica-
tions were 1% of tolerance and 0.8% optimization, using a cutoff
similarity value of 90% that corresponded to up to 5 bands
difference in macrorestriction band patterns, when analyzed
visually. Isolates were considered to belong to the same PFGE
type when they were put together in the same cluster, after
automatic clustering analysis, using the parameters mentioned
above. Unique band patterns within each PFGE type were
considered as PFGE subtypes.
Genetic diversity and clonality of MRSHo
The molecular characterization of MRSHo isolates by PFGE
classified the 34 isolates into 28 PFGE types (A–AA), revealing an
extremely high genetic diversity (SID=98.75% for the PFGE type
and SID=99.82% for the PFGE subtype) (Figure 1). Six PFGE
types (A, C, F, O, R, and X) contained two isolates each, and the
remaining 22 isolates were included in unique types (Table 1). The
combination of clinical and typing data revealed that MRSHo
belonging to the same PFGE type were found with a 3-year
interval in the same unit. This is the case, for example, of isolates
of PFGE types A1 and A2 that were collected from two different
patients in the hematological unit in 2002 and 2004, respectively.
Moreover, cross dissemination of MRSHo among patients in the
same ward and across different wards was also observed. This was
illustrated clearly, by isolates of PFGE type R1 and R2 that were
isolated from two patients both in the Graft Unit within a three
year period; and by isolates of PFGE types X that were isolated
within a five month interval from one patient in the Graft Unit
and another in the Hematological Unit (Table 1).
In spite of the few examples of dissemination of S. hominis
isolates, we could observe that, with the exception of two isolates
(PFGE G), a unique PFGE subtype was associated to each patient.
The results illustrate well the low clonality of the species.
Antibiotic susceptibility patterns
The antibiotic susceptibility to a panel of 22 antibiotics and the
MIC for oxacillin was determined for the 34 mecA-positive
MRSHo. A total of 28 out of 34 isolates (80%) expressed
phenotypic methicillin resistance (1.5 mg/ml). However, six
isolates were susceptible to oxacillin in both disc diffusion and E-
test (MICs 0.047–1.5 mg/ml), in spite of the fact they carried mecA;
this discrepancy was not investigated further, but might be due to
the presence of point mutations in mecA that can lead to the
production of a less active PBP2a or two the existence of extremely
heterogeneous oxacillin resistance profiles, that could not be
detected by the methods used.
All MRSHo isolates were resistant to at least one of the non-b-
lactam antibiotics tested, as follows: 29 (85%) were resistant to
cotrimoxazole, 29 (85%) to fusidic acid, 25 (73%) to kanamycin,
23 (67%) to erythromycin, 21 (62%) to tobramycin, 18 (53%) to
gentamicin, 18 (53%) to ofloxacin, 17 (50%) to ciprofloxacin, 16
(47%) to tetracycline, 15 (44%) to clindamycin, 6 (17%) to
fosfomycin, 4 (12%) to rifampin and 3 (9%) to chloramphenicol.
All the isolates were susceptible to pristinamycin, vancomycin and
teicoplanin. As many as 94% of MRSHo isolates were multidrug-
resistant.
No correlation was found between the PFGE type/subtype and
the antibiogram profile. Although we found isolates with the same
PFGE type (PFGE C) and the same highly resistant antibiotype,
we also found cases where two isolates with exactly the same
PFGE subtype (PFGE X), exhibited either resistance to seven
different antimicrobial agents or susceptibility to all the antimi-
crobial agents tested (Table 1).
SCCmec distribution in S. hominis
The molecular characterization of the SCCmec carried by
MRSHo showed that SCCmec VI (4B) was carried by 20% of the
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MRSHo strains (38%, 13 out of 34) carried a unique new
association between the mec complex class and the ccr complex,
corresponding to ccrAB1 associated to mec complex type A (1A). In
addition, a high number of non-typeable SCCmec structures (27%)
were also found, that resulted from the finding of a single mec
complex and two different ccr complex allotypes in the same
isolate. They included: mec complex class A, ccrAB1 and ccrAB4
(NT1) (two isolates); mec complex class A, ccrAB1 and ccrC (NT2)
(two isolates); and class A, ccrAB4 and ccrC (NT3) (one isolate).
These results may correspond to the existence of a SCCmec type
with two ccr complexes (like SCCmec type III), or the existence of a
SCCmec in tandem with a SCC non-mec. In addition, two isolates
carried mec complex type A but none of the ccr genes described so
far and in two isolates neither ccr nor mec complexes were typeable,
although mecA was present. This may correspond either to new
SCCmec type structures or to remnants of SCCmec that have lost
the ccr complex.
Overall a high frequency of mec complex class A (73.5%) and
ccrAB1 (50%) and ccrAB4 (44%) was observed among MRSHo.
Regarding the distribution of SCCmec among the different
PFGE types, we found cases where isolates with the same PFGE
type (PFGE types A, O and R) carried the same SCCmec type (4B,
1A, and 4A, respectively). However, we also observed that the
same SCCmec could be carried by isolates of different PFGE types.
For example, SCCmec 1A was carried by as many as 12 different
Figure 1. PFGE profiles after XhoI digestion of methicillin-resistant S. hominis isolates. The dendrogram showing the clustering of strains
was performed by analysis of PFGE profiles with the Bionumerics software, with 1% tolerance and 0.8% optimization (this study). Clusters were
defined at a cut-off value of 90%.
doi:10.1371/journal.pone.0021940.g001
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PFGE types (Table 1), suggesting either multiple acquisitions of
SCCmec or the existence of a highly adaptive and diverse clone.
Identification of ccrAB and ccrC genes in mecA-negative
S. hominis isolates
The presence of ccr genes among MSSHo isolates was tested by
Southern hybridization followed by ccr typing. Among the 11 mecA-
negative isolates analyzed, three harbored ccrC, two carried ccrAB1,
two ccrAB4, and one isolate carried ccrAB2. We also found one
isolate that showed to carry the ccr genes by Southern
hybridization but that was non-typeable by ccr typing by PCR.
All these ccr genes found among MSSHo probably belong to SCC
non-mec elements. Interestingly, all except three of the isolates
carrying ccr genes showed resistance to three or more antimicrobial
classes (Table 2). From the two MSSHo isolates recently
sequenced, only one of the isolates (K119) carried a cassette
chromosome recombinase with high homology with ccrC from the
SCCmec V, which appears to be located far away from the orfX
region (draft sequence data). Similarly to our findings, both strains
Table 1. Molecular and phenotypic characterization of methicillin-resistant S. hominis (MRSHo) isolates.
Strain Date of Ward
a Clinical
b MIC Ox mecA
c SCCmec typing
d
Resistance profile
e
PFGE
cluster
isolation product (mg/ml) mec complex ccr type SCCmec
6074ae ´ 31-12-02 HU Bl 0.5 + class B type 4 VI P, Ox, E, SXT, Fu A1
4488 09-08-04 HU Ca 0.5 + class B type4 VI P, S, K, E, Rf, SXT, Fu A2
2772 18-05-04 HU Ca 0.38 + class B type 4 VI P, Ox, Of, Cp, fo, Fu B
5162a 09-11-02 HU ISCa 1.5 + class A type 1 new1 P, Ox, Amx, G, K, T, L, Tc, SXT, Of, Cp, Fu C1
3030a 08-07-03 HU Ca 3 + class A type 1+4 NT1 P, Ox, Amx, G, K, T, L, Tc, SXT, Of, Cp, Fu C2
4244 24-09-03 HU Ca 0.19 + NT NT NT P, K, E, Tc D
3140ae ´ 18-07-03 HU Bl 8 + class A type 1 new1 P, Ox, Amx, Amc, S, G, K, T,E, L, Tc, Ch, SXT, Fu E
2060 07-05-03 GU Ca .256 + class A NT NT P, Ox, Amx, Amc, G, K, T, E, L, Tc, SXT, Fo, Fu F1
5305ae ´ 02-10-04 HU Bl .256 + class A type 1 new1 P, Ox, Amx, G, K, T, E, SXT, Of, Cp, Fu F2
4842 24-10-02 GU ISCa .256 + class A type 4 VIII P, Ox, Amx, G, K, T, E, L, Tc, SXT, Fo, Fu G
4793a 21-10-02 GU Bl 0.047 + class A type 4+ccrC NT4 L H
2916 30-06-03 GU Ca 1.5 + class A type 4 VIII P, Ox, S, G, K, T, E, Ch, SXT, Fu I
3503an 21-06-04 GU Bl .256 + class A type 1 new1 P, Ox, G, K, T, Amc, E, SXT, Of, Cp, J
1596a 10-04-03 HU Ca 0.75 + class B type 4 VI P, Ox, K, E, SXT, Fu K
2734an 17-05-04 GU Bl 4 + class A type 1 new1 P, Ox, T, E, L, SXT, Of, Cp, Fu L
2183 13-05-03 HU Ca 0.19 + class A type 1 new1 P, Ox, G, K, T, E, SXT, Of, Cp, fo, Fu M
1781 22-04-03 GU Ca 0.064 + class A type 1+ccrC NT2 P, G, K, T, E, SXT, Of, Cp, Fu N
5486 26-11-02 HU ISCa 6 + class A type 1 new1 P, Ox, Amx, G, K, T, E, Tc, SXT, Fu O1
6624ae ´ 06-12-04 HU Bl 6 + class A type 1 new1 P, Ox, G, K, T, E, L, Tc, SXT, Of, Cp, Fu O2
5666 09-12-02 GU ISCa 4 + class A type 1+ccrC NT2 P, Ox, T, E, SXT, L, Rf, SXT, Of, Cp, Fu P
2927b 01-07-03 GU Ca .256 + class A type 1 new1 P, Ox, Amx, Amc, G, K, T, L, SXT, Of, Cp, Fu Q
2730 27-06-02 GU ISCa 0.19 + class A type4 VIII P, Ox, Amx, G, K, T, L, Tc, SXT, Fu R1
4037b 20-09-02 GU ISCa 4 + class A type4 VIII P, Ox, T, E, L, SXT, Of, Cp, Fu R2
2762b 26-06-02 HU ISCa 24 + class A type4 VIII P, Ox, Amx, G, K, T, L, Tc, SXT, Fu S
312a 20-01-03 HU Ca 12 + class A type 1 new1 P, Ox, Amx, G, K, Tc, SXT, Fu T
1561 19-03-04 HU Bl 4 + class A type 1 new1 P, Ox, G, K, T, E, Tc, SXT, Of, Cp, Fu U
4866b 21-10-03 HU Pu 1.5 + class A type 1+4 NT1 P, Ox, G, K, T, E, L, Tc, SXT, Of, Cp, fo, Fu V
834b 11-02-04 GU Ca 4 + class A type 1 new1 P, Ox, Amx, K, Tc, Rf, SXT X1
4244 27-07-04 HU Ca 0.094 + NT NT NT - X2
5262b 13-11-02 HU ISCa .256 + class A NT NT P, Ox, Amx, G, K, T, E, Tc, SXT, Fo, Fu Z
2320 26-04-04 HU Bl 0.25 + class B type4 VI P, Ox, Amx, Amc, K, E, L, Rf, SXT, Of, Cp, Fu Y
3070a 31-05-04 HD Pu 0.38 + class B type4 VI P, Ox, E, Tc, SXT, Of, Cp, Fu W
4866an 04-09-04 HU Bl 8 + class A type 1 new1 P, Ox, Amx, K, T, Tc, Fu AA
aHU: hematological unit; HG: graft unit; HD: hospital day;
bBl: blood; Ca: catheter; ISCa: insertion site of catheter; Pu: pus;
c+, mecA gene present;
dNT: not typeable;
eP: penicillin G; Ox: oxacillin; S: streptomycin; G: gentamicin; K: kanamycin; T: tobramycin; E: erythromycin; L: lincomycin; Amx: amoxicillin; Amc: amoxicillin-acid
clavulanic; Tc: tetracycline; Ch: chloramphenicol; Cp: ciprofloxacin; Of: ofloxacin; SXT: cotrimoxazole; Rf: rifampin; Fo: fosfomycin; Fu: fusidic acid.
doi:10.1371/journal.pone.0021940.t001
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not carry the gene mecA.
Nucleotide homology between ccrB from S. hominis and
other Staphylococcus species
In order to verify if ccrAB4 and ccrAB1 found in S. hominis were
similar to those previously described, ccrB typing was performed
for all MRSHo and MSSHo carrying a single ccrAB allotype (28
MRSHo and 5 MSSHo). A high homology (97–99%) was found
between ccrB1 from S. hominis isolates from our study and those of
ccrB1 of other S. hominis isolates in the database (SH13-27 and
SH8-39). More interesting, a similar homology was found between
ccrB1 from our collection and the ccrB1 from S. epidermidis (SE6-42).
Likewise, S. hominis ccrB4 showed a high nucleotide sequence
homology (92 to 96.5%) with ccrB4 from S. aureus (HDE288)
(Figure 2).
Thirteen out of the 33 isolates were non-typeable by ccrB typing
methodology, because of the presence of several superimposed
peaks in sequence’s traces. As ccrB typing makes use of
degenerated primers, the existence of superimposed peaks may
indicate the presence of multiple ccr alleles of the same allotype,
which the PCR multiplex methodology is unable to detect.
We also found four isolates for which PCR-based typing
indicated the presence of ccrAB1, but ccrB sequencing indicated the
presence of ccrAB4 (5162a, 3140ae ´, 5486, and 1561). The results
suggest that these isolates carry the two ccrB allotypes (ccrB1 and
ccrB4). However they could not be both detected by the same
methodology most probably due to nucleotide differences in the
primer regions used. Altogether, these apparently discrepant
results, suggests a large pool of ccrAB1 and ccrAB4 alleles in S.
hominis.
A total of four different ccrB1 and 10 different ccrB4 alleles were
found in the 14 isolates from our collection, for which a ccrAB
allotype could be determined. The phylogenetic relationships
among ccrB1 and ccrB4 alleles found in this study with those of
control strains available in the database [44] are displayed in
Figure 2. The ccrB4 alleles were clustered into three different
branches: one containing the ccrB4 from the SCCpbp4 of S.
epidermidis strain ATCC12228; the other containing SCCmec VI
prototype S. aureus strain (HDE288), SCCmec VIII prototype S.
aureus strain (10682) and four isolates from our study (5162a,
3140ae ´, 5486, and 1561); and the last one containing only four
MRSHo (4793a, 2762b, 3070a, 4364a) and two MSSHo isolates
(2573b, 2910) from our collection.
The ccrB1 allele was present in several species in the ccrB
database, being distributed in one major cluster that contained
three prototype S. aureus strains for ccrAB1 (COL, PER184, PL72),
one S. epidermidis isolate (SE 6–42), one S. hominis (SH 13–27) isolate
from the database and three S. hominis isolates from our collection
(two MRSHo and one MSSHo). The remaining five isolates were
distributed by five different branches (S. fleuretti H65; S. aureus
MSSA4476, S. hominis 2189 from our study, S. hominis SH8-39, and
S. haemolyticus D64).
The phylogenetic analysis showed that ccrAB1 and ccrAB4 from
S. hominis and those found in S. aureus SCCmec are highly similar
and must have had a common origin.
Discussion
This study is the first to describe the molecular epidemiology of
nosocomial Staphylococcus hominis species. Our data showed that S.
hominis population was composed of a very high number of PFGE
types and subtypes, suggesting that each S. hominis clone as defined
by PFGE can eventually be host specific and is only rarely
disseminated. However, we also found S. hominis isolates that were
isolated with a 3-year interval in the same hospital. The results
indicate that the great majority of S. hominis infections most
probably have originated from the endogenous flora of patients,
rather than acquired from the environment or from cross
transmission. However, only the study of isolates collected from
healthy persons in the community with no recent hospital contact
will enable to confirm this hypothesis.
The PFGE protocol optimized in this study illustrated well the
genetic diversity of S. hominis population, however it may have
been too discriminatory, since it was not able to detect relatedness
Table 2. Molecular and phenotypic characterization of the 11 methicillin-susceptible S. hominis (MSSHo) isolates.
Strain Date of Ward
a Clinical MIC Ox mecA
c SCCmec typing
d
Resistance profile
e
isolation Product
b (mg/ml) mec complex ccr type SCCmec
2573b 17-06-02 HU Ca 0.19 - NT type4 NT P, E, Tc
2189 13-05-03 HU Bl 0.125 - NT type 1 NT P, Ox, Amx, S, G, K, T, E, Ch, Rf, SXT, Of, Cp, Fu
3606a 21-08-03 HU Th 0.125 - NT NT NT S
2910 30-06-03 GU Bl 0.19 - NT type4 NT P, Amx, SXT, Fu
1342b 25-03-03 GU Ca 0.19 - NT type 2 NT P, Ox, Amx, G, K, T, E, SXT, Of, Cp, Fu
17569 21-04-03 DH Bl 0.19 - NT ccrC NT P, Ox, E, L,
1839a 25-04-03 HU Bl 0.25 - NT NT NT P, S, K, E, L, Tc,
2347a 27-04-04 HU Ca 0.064 - NT ccrC NT P
2654A 13-05-04 GU Bl 0.064 - NT ccrC NT -
5425 09-10-04 HU Al 0.047 - NT type 1 NT -
3707b 01-07-04 HU Bn 0.064 - NT NT NT P, Tc, Fo
aHU: hematological unit; GU: graft unit; DH: day hospital;
bBl: blood; Ca: catheter; Th: throat; Al: alimentation parenteral; Bn: bone fragment;
c- mecA gene absent;
dNT: not typeable;
eP: penicillin G; Ox: oxacillin; S: streptomycin; G: gentamicin; K: kanamycin; T: tobramycin; E: erythromycin; L: lincomycin; Amx: amoxicillin; Tc: tetracycline; Ch:
chloramphenicol; Cp: ciprofloxacin; Of: ofloxacin; SXT: cotrimoxazol; Rf: rifampin; Fu: fusidic acid.
doi:10.1371/journal.pone.0021940.t002
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diversity observed may result from the existence of multiple
transposases and integrases in the genome, as revealed by the
analysis of the genome available for two S. hominis strains. To
further clarify the origin of genetic diversity in this species it will be
essential to develop a multilocus sequence typing scheme for S.
hominis.
In spite of the low clonality of S. hominis, almost every isolate of
this species was found to be multidrug resistant, accumulating
resistance to virtually all classes of antimicrobial agents, particu-
larly resistance to aminoglicosides, erythromycin, cotrimoxazole,
and fosfomycin. The finding of multidrug resistance among S.
hominis from this study that are part of an established resident flora
may result from the long internment periods and aggressive and
continuous antibiotic therapy that neutropenic patients are
subjected to. This fact may turn this staphylococcal species into
a particularly privileged reservoir and donor for other species
sharing the same ecological niche, like S. epidermidis, S. haemolyticus
and S. aureus [45].
Another interesting feature of S. hominis molecular epidemiology
was the finding of a high frequency of SCCmec types containing
ccrAB4, ccrAB1 and mec complex A in its composition, like VI (4B),
SCCmec VIII (4A) and a new SCCmec type with mec complex class
A associated to ccrAB1 (1A), and the complete absence of SCCmec
structures containing ccrAB2, ccrAB3, ccrC and mec complex C.
Previous studies where SCCmec was characterized for only a few S.
hominis isolates also showed that S. hominis predominantly carried,
ccrAB1, ccrAB4 and mec complex A [18,46]. Most importantly, we
found that ccrB1 and ccrB4 from both MRSHo and MSSHo
analyzed here had a high homology with those ccrAB allotypes of
prototype strains of S. aureus carrying SCCmec type I and VI,
respectively. Altogether, the results suggest that S. hominis,i sa n
important reservoir of ccrAB1, ccrAB4 and mec complex A and
could have been the donor of these components to the assembly of
SCCmec types I, VI, VIII, and the new type 1A. Another
observation resulting from our study that sustains this hypothesis
was the finding of ccrB internal regions of MRSHo (carrying
SCCmec VI and the new SCCmec 1A) with 100% homology with
those of MSSHo what suggests that already pre-existing SCC non-
mec carrying these ccrAB allotypes could have been the receptors of
mec gene complex to give rise to SCCmec. Moreover, the finding in
our study of a high number of ccrB1 and ccrB4 alleles among the
small number of S. hominis analyzed, suggests that these ccr
allotypes have been in S. hominis long enough to be able to diversify
and could have been the species where these ccr allotypes were
once originated.
In what respects to the origin of SCCmec type VI (4B) and VIII
(4A), no previous studies documented their link to S. hominis or any
other species. However, the involvement of S. hominis in the
assembly of SCCmec I was previously suggested due to the finding
Figure 2. Phylogram (average distance) using the identity percentage for ccrB1 and ccrB4 carried by S. hominis isolates and ccrB
prototype sequences available on 17 June 2010 at the ‘ccrB typing tool’ online resource. The tree was automatically drawn by the Java
applet available through the ‘ccrB typing tool’ using the default parameters [14]. MRSHo and MSSHo isolates from this study are underlined. Control
isolates were the following by order of appearance from top to bottom: ATCC12228, Methicillin-susceptible S. epidermidis (MSSE) strain; carrying the
SCCpbp4; HDE288, methicillin-resistant S. aureus (MRSA), carrying SCCmec VI; C10682, MRSA carrying SCCmec type VIII; H65, S. fleuretti isolate from
database carrying ccrAB4 from ccrB typing tool database; GIFU1223, MSSHo strain GIFU1223 (ATCC27844), carrying the SCC1223; SH-8-39, S. hominis
isolate carrying ccrAB1 from the database; D64, S. haemolyticus isolate carrying ccrAB1 from the database; PER184, MRSA, carrying SCCmec I; COL,
MRSA carrying SCCmec I; PL72, MRSA carrying SCCmec I; SE6-42, S. epidermidis isolate from the database, carrying ccrAB1; SH13-27, S. hominis from
the database carrying ccrAB1; MSSA476, methicillin-susceptible S. aureus (MSSA), carrying SCCMSSA476. SA, S. aureus; SE, S. epidermidis; SHo, S. hominis;
SHa, S. haemolyticus; SF, S. fleuretti.
doi:10.1371/journal.pone.0021940.g002
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the SCCmec I from S. aureus [12]. In this study we identified a high
number of S. hominis isolates carrying a new SCCmec type where
ccrAB1 was associated to mec complex A, with intact mecI and
mecR1. We believe that this new SCCmec type could have been the
most direct precursor of SCCmec type I that emerged from the
latter by mecI and mecR1 IS1272-mediated deletion. However,
most probably this deletion step did not occur in S. hominis since no
IS1272 transposases were found in its genomes (http://www.ncbi.
nlm.nih.gov/genome?Db=genome&Cmd=ShowDetailView&T
ermToSearch=7149;http://www.ncbi.nlm.nih.gov/genome?Db
=genome&Cmd=ShowDetailView&TermToSearch=6409).
The methodology used in this study for the definition of SCCmec
types in MRSHo was only based on PCR data for the two central
elements of SCCmec – the mec complex and ccr complex. Although
in S. aureus this is considered to be a valid approach, for CoNS
species the SCCmec distribution and structure is still elusive and
caution should be taken in interpretation of data. One limitation of
the approach used is that it did not take into consideration the
proximity of the two elements in the chromosome. Although the
conclusions taken are the most parsimonious, the methodology
used does not allow us to state that two elements found in the same
isolate belong to the same SCC.
The prevalence of specific mec complex classes and ccr allotypes
observed in this study was previously detected in other CoNS
species like mec complex C in S. haemolyticus and mec complex B and
ccrAB2 in S. epidermidis [46,47], suggesting that each CoNS might
be a reservoir for specific and different components of the SCCmec
types identified in S. aureus (Figure 3).
The study described here showed that S. hominis has a distinctive
genetic diversity and has contributed in a specific mode to the
assembly of SCCmec. The results emphasize the urgent need for
studying each CoNS species as a separate entity with its own
features and characteristics. Only by understanding the molecular
epidemiology of the individual CoNS species it will be possible in
the future to design effective infection control strategies against
these microorganisms and understand their contribution for the
evolution of the broad-spectrum beta-lactam determinant.
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